ASE Details M-TEER Imaging Guidance - Scorecard - MDSpire

ASE Details M-TEER Imaging Guidance

  • By

  • Conexiant News Staff

  • June 22, 2026

  • 9 min

Share

Clinical Scorecard: ASE Details M-TEER Imaging Guidance

At a Glance

CategoryDetail
ConditionMitral Valve Transcatheter Edge-to-Edge Repair (M-TEER)
Key MechanismsStandardization of intraprocedural imaging and communication to improve procedural success and patient outcomes.
Target PopulationPatients undergoing M-TEER procedures.
Care SettingInterventional cardiology and echocardiography.

Key Highlights

  • Guidelines aim to standardize imaging protocols and communication among clinicians.
  • Greater institutional experience correlates with improved procedural outcomes.
  • Recommendations cover various imaging modalities including 2D, 3D, and MPR.
  • Stepwise imaging protocol includes nine procedural stages.
  • Eligibility for M-TEER is based on multiparametric assessment.

Guideline-Based Recommendations

Diagnosis

  • Confirm severity and mechanism of mitral regurgitation (MR) during baseline evaluation.
  • Assess ventricular function and identify contraindications.

Management

  • Use 3D MPR for improved procedural guidance and communication.
  • Standardize image orientation and nomenclature throughout the procedure.

Monitoring & Follow-up

  • Assess residual MR and transmitral gradient before device deployment.

Risks

  • An MVA below 3.5 cm² is often a contraindication to M-TEER.

Patient & Prescribing Data

Patients with mitral regurgitation suitable for transcatheter repair.

Minimum posterior leaflet length requirements vary by device type.

Clinical Best Practices

  • Maintain appropriate height and alignment during transseptal puncture.
  • Confirm adequate leaflet insertion and tissue capture before device deployment.

Related Resources & Content

Original Source(s)

Related Content